On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Jabil Inc. (NYSE:JBL), adding that it is “such a good company.”
On Sept. 26, Jabil reported better-than-expected fourth-quarter financial results and approved a $1 billion share buyback. Jabil reported fourth-quarter revenue of $6.96 billion, down by 17.7% year-on-year, beating the analyst consensus estimate of $6.59 billion. The print manufacturing company’s adjusted EPS of $2.30 beat the analyst consensus estimate of $2.22.
When asked about MeiraGTx Holdings plc (NASDAQ:MGTX), he said, “Put it away, speculate. If something great happens, terrific. If not, you won't even notice.”
On Oct. 15, MeiraGTx released topline data from its clinical bridging study of AAV-GAD for Parkinson's disease, MGT-GAD-025. MGT-GAD-025 is a 6-month, three-arm, randomized, double-blind, sham-controlled study using AAV-GAD drug product manufactured by MeiraGTx at its wholly-owned facilities with its commercial platform process.
SoFi Technologies, Inc. (NASDAQ:SOFI) is good, Cramer said.
On Oct. 29, SoFi reported third-quarter adjusted sales of $689.445 million, beating analyst estimates of $632.328 million, according to Benzinga Pro.
The company reported third-quarter earnings of 5 cents per share, beating estimates of 4 cents per share. SoFi raised its full-year revenue forecast from a range of $2.425 billion to $2.465 billion to a new range of $2.535 billion to $2.55 billion versus estimates of $2.45 billion, according to Benzinga Pro.
Price Action:
- MeiraGTx shares gained 4.8% to settle at $6.73 on Thursday.
- Jabil shares fell 0.3% to close at $137.30 on Thursday.
- SoFi shares gained 0.8% to settle at $11.90 during the session.
Read Next:
Image: Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
